Literature DB >> 3416170

Recurrent otitis media and pulmonary infiltrates as presenting features in Wegener's granulomatosis.

M G Ridley1, C S Wolfe, R A Asherson, G R Hughes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3416170      PMCID: PMC1834067          DOI: 10.1136/bmj.297.6644.352

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis).

Authors:  E W WALTON
Journal:  Br Med J       Date:  1958-08-02

2.  Necrotizing vasculitis after acute serous otitis media.

Authors:  J S Sergent; C L Christian
Journal:  Ann Intern Med       Date:  1974-08       Impact factor: 25.391

Review 3.  Wegener's granulomatosis: isolated involvement of the trachea and larynx.

Authors:  D Hellmann; T Laing; M Petri; D Jacobs; R Crumley; M Stulbarg
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103

4.  The use of alkylating agents in the treatment of Wegener's granulomatosis.

Authors:  D Hollander; R T Manning
Journal:  Ann Intern Med       Date:  1967-08       Impact factor: 25.391

5.  Limited forms of angiitis and granulomatosis of Wegener's type.

Authors:  C B Carrington; A Liebow
Journal:  Am J Med       Date:  1966-10       Impact factor: 4.965

6.  Bioptic diagnosis of Wegener's granulomatosis in the absence of vasculitis and granulomas.

Authors:  I A Shah; A Holstege; U N Riede
Journal:  Pathol Res Pract       Date:  1984-03       Impact factor: 3.250

  6 in total
  3 in total

1.  Wegener's granulomatosis--another challenging case.

Authors:  Henricus van den Heuvel
Journal:  BMJ Case Rep       Date:  2011-07-20

2.  Ear, nose, and throat symptoms in subacute Wegener's granulomatosis.

Authors:  D P D'Cruz; E Baguley; R A Asherson; G R Hughes
Journal:  BMJ       Date:  1989-08-12

3.  Wegener's disease presenting with occipital condyle syndrome.

Authors:  Alejandro Hornik; Federico Rodriguez-Porcel; Cagatay H Ersahin; Ruth Kadanoff; José Biller
Journal:  Front Neurol       Date:  2012-04-12       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.